Patents by Inventor Bernard Cuenoud

Bernard Cuenoud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
    Publication number: 20070249586
    Abstract: Compounds of formula (I) in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: June 27, 2007
    Publication date: October 25, 2007
    Inventors: Bernard Cuenoud, Robin Fairhurst, Roger Taylor, David Beattie
  • Quinoline-2-one derivatives for the treatment of airways diseases
    Publication number: 20070066607
    Abstract: Compounds of formula I free or salt form, wherein —C—Y—, R1 and R2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
    Type: Application
    Filed: April 2, 2004
    Publication date: March 22, 2007
    Inventors: Robin Fairhurst, David Sandham, David Beattie, Ian Bruce, Bernard Cuenoud, Reamonn Madden, Neil Taylor, Roger Taylor, Katharine Turner, Simon Watson
  • Inhibitors of phosphatidylinositol 3-kinase
    Publication number: 20070032487
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
    Type: Application
    Filed: April 30, 2004
    Publication date: February 8, 2007
    Inventors: Ian Bruce, Bernard Cuenoud, Thomas Keller, Gaynor Pilgrim, Nicola Press, Darren Le Grand, Cathy Ritchie, Barbara Valade, Judy Hayler, Emma Budd
  • 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
    Publication number: 20060148822
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: March 5, 2004
    Publication date: July 6, 2006
    Inventors: Graham Bloomfield, Ian Bruce, Catherine Leblanc, Mrinalini Oza, Lewis Whithead, Bernard Cuenoud, Thomas Keller, Louise Kirman, Clive McCarthy, Gaynor Woodward
  • Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
    Publication number: 20060106075
    Abstract: Compounds of formula (I) in free or salt or solvate form, wherein X has the meaning indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: August 8, 2003
    Publication date: May 18, 2006
    Inventors: Bernard Cuenoud, Robin Fairhurst, Roger Taylor, David Beattie
  • Combination of formoterol and a tiotropium salt
    Publication number: 20060083692
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: November 29, 2005
    Publication date: April 20, 2006
    Inventors: Ian Hassan, Jeremy Clarke, Bernard Cuenoud
  • Mixtures or organic compounds for the treatment of airway diseases
    Publication number: 20060052352
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: October 12, 2005
    Publication date: March 9, 2006
    Inventors: Bernard Cuenoud, Robin Fairhurst, Nicholas Lowther
  • Mixtures or organic compounds for the treatment of airway diseases
    Patent number: 7008951
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: March 7, 2006
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Organic compounds
    Patent number: 6921757
    Abstract: Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: July 26, 2005
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, David Beattie, Thomas Hugo Keller, Gaynor Elizabeth Pilgrim, David Andrew Sandham, Simon James Watson
  • 2'-Substituted nucleosides and oligonucleotide derivatives
    Publication number: 20050159374
    Abstract: The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I) The invention furthermore relates to nucleoside building blocks, intermediates and processes for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.
    Type: Application
    Filed: October 29, 2003
    Publication date: July 21, 2005
    Inventors: Bernard Cuenoud, Karl-Heinz Altmann, Pierre Martin, Heinz Moser
  • Beta2-adrenoceptor agonists
    Publication number: 20050153957
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: March 7, 2005
    Publication date: July 14, 2005
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Fairhurst, David Beattie
  • Beta2-adrenoceptor agonists
    Patent number: 6878721
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: April 12, 2005
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Mixtures or organic compounds for the treatment of airway diseases
    Publication number: 20050009795
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: August 4, 2004
    Publication date: January 13, 2005
    Inventors: Bernard Cuenoud, Robin Fairhurst, Nicholas Lowther
  • Mixtures for organic compounds for the treatment of airway diseases
    Patent number: 6800643
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: June 4, 2003
    Date of Patent: October 5, 2004
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Organic compounds
    Publication number: 20040038951
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: June 4, 2003
    Publication date: February 26, 2004
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • 2?-substituted nucleosides and oligonucleotide derivatives
    Patent number: 6670468
    Abstract: The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I) The invention furthermore relates to nucleoside building blocks, intermediates and processes for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: December 30, 2003
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Karl-Heinz Altmann, Pierre Martin, Heinz Ernst Moser
  • Organic compounds
    Publication number: 20030158163
    Abstract: Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 21, 2003
    Inventors: Bernard Cuenoud, David Beattie, Thomas Hugo Keller, Gaynor Elizabeth Pilgrim, David Andrew Sandham, Simon James Watson
  • Combination of formoterol and a tiotropium salt
    Publication number: 20030125350
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: February 12, 2003
    Publication date: July 3, 2003
    Inventors: Ian F. Hassan, Jeremy G. Clarke, Bernard Cuenoud
  • Combinations of formoterol and a tiotropium salt
    Patent number: 6537524
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: March 25, 2003
    Assignee: Novartis AG
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Bernard Cuenoud
  • Catalytic DNA having ligase activity
    Patent number: 5910408
    Abstract: The invention features nucleic acid molecules and, in particular, DNA molecules having catalytic activity, as well as methods for obtaining and using such nucleic acid molecules.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 8, 1999
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Bernard Cuenoud, David E. Huizenga